
New Journal of Chemistry p. 11607 - 11618 (2017)
Update date:2022-08-11
Topics:
Banerjee, Saikat
Brand?o, Paula
Bauzá, Antonio
Frontera, Antonio
Barceló-Oliver, Miquel
Panja, Anangamohan
Saha, Amrita
A novel mononuclear Mn(iii) complex, [MnIII(L1)Cl(H2O)]·H2O (1), and a tetranuclear Zn(ii)-Mn(ii) complex, [{ZnII2(L2)2Cl2}MnII2(μ1,1-N3)2(H2O)2]·2H2O (2), have been synthesized involving azo Schiff base ligands, viz. H2L1 = (E)-6,6′-((1E,1′E)-(ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-methoxy-4-((E)-p-tolyldiazenyl)phenol) and H2L2 = (E)-6,6′-((1E,1′E)-((2,2-dimethylpropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-methoxy-4-((E)-p-tolyldiazenyl)phenol), respectively. The solid-state structures were determined by single crystal X-ray crystallography. In complex 1, the Mn(iii) centre adopts slightly distorted octahedral geometry, while in complex 2 the Mn(ii) centre residing in the outer core of the ligand adopts a distorted pentagonal bipyramidal geometry. In complex 1, the chloride ion simply acts as a terminal coligand, while in complex 2, azide ions bind the metal centres in an end-on bridging fashion to produce a tetranuclear complex. The phenoxazinone synthase-like activity of both complexes has been examined and a detailed investigation of the structure-property correlation has been performed. Whereas the mononuclear complex 1 exhibits significant phenoxazinone activity, complex 2 is almost inactive, although in both complexes labile sites are available at manganese centres for substrate binding. The present work therefore highlights the importance of higher oxidation states of manganese over nuclearity for the development of better in vitro catalysts. In addition, extensive efforts have been made to visualize and quantify all supramolecular interactions present in 1 and 2.
View More
Weifang Yuexiang Chemical Co.,Ltd
Contact:86-536-8734188
Address:Economic development zone Weifang city ,Shandong province ,China
Shangyu Sanhechemicals Co.,LTD.
Contact:86-0571-56696839
Address:Num.2952,Nanhuan Road,Binjiang District,Hangzhou,China
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
JinTan Pingsheng Chemical Co.,Ltd
Contact:+86-519-82828200
Address:NO.11Danfengxilu Road,Jintan City,Jiangsu,China
Doi:10.1002/cssc.201800670
(2018)Doi:10.1039/c7gc01116d
(2017)Doi:10.1016/j.ejps.2020.105466
(2020)Doi:10.1039/c7ta03786d
(2017)Doi:10.1016/j.ejmech.2017.04.027
(2017)Doi:10.1021/jm00159a009
(1986)